期刊文献+

杂交前3%过氧化氢预处理增强EBER原位杂交特异性阳性信号

Pretreatment with 3%hydrogen peroxide before hybridization enhances specific positive signal of EBER in situ hybridization
下载PDF
导出
摘要 目的优化EBER原位杂交检测方法,增强特异性阳性信号,降低背景染色。方法选取30例EBV阳性的组织切片,在杂交前处理时加入3%过氧化氢,再通过EBER探针进行原位杂交,比较不同过氧化氢孵育时间对杂交反应阳性信号和背景的影响。结果用3%过氧化氢处理鼻咽癌组织10 min、处理淋巴瘤组织15 min,EBER原位杂交阳性信号强,背景干净。结论EBER原位杂交过程中,在杂交前处理时用3%过氧化氢短暂孵育可以增强特异性阳性信号,降低非特异性背景染色。 Objective Optimize EBER in situ hybridization method to enhance specific positive signals and reduce background staining.Methods 30 EBV positive tissue sections were selected,and 3%hydrogen peroxide was added during pre-hybridization treatment,and EBER probe was used for in situ hybridization.The influence of different incubation time of hydrogen peroxide on the positive signal and background of hybridization reaction was compared.Results Treatment with 3%hydrogen peroxide of nasopharyngeal carcinoma tissue for 10 minutes and lymphoma tissue for 15 minutes showed strong positive signals of EBER in situ hybridization and a clean background.Conclusion During the EBER in situ hybridization process,short-term incubation with 3%hydrogen peroxide before hybridization can enhance specific positive signals and reduce non-specific background staining.
作者 王殿军 施洋 陈淼 Wang Dianjun;Shi Yang;Chen Miao(Department of Pathology,Zhenjiang first people’s Hospital,Zhenjiang212002,China)
出处 《中国组织化学与细胞化学杂志》 CAS CSCD 2023年第3期297-299,共3页 Chinese Journal of Histochemistry and Cytochemistry
关键词 EBER原位杂交 3%过氧化氢预处理 特异性杂交信号 EBER in situ hybridization pretreatment with 3%hydrogen peroxide specific hybridization signal
  • 相关文献

参考文献8

二级参考文献42

  • 1胡长诚.有机过氧化物提价[J].化学推进剂与高分子材料,2005,3(1):51-51. 被引量:1
  • 2周小鸽.免疫组化染色过程中存在的问题及对策[J].诊断病理学杂志,2004,11(4):211-213. 被引量:19
  • 3YunWang,BingLuo,Li-PingYan,Bao-HuaHuang,PengZhao.Relationship between Epstein-Barr virus-encoded proteins with cell proliferation,apoptosis,and apoptosis-related proteins in gastric carcinoma[J].World Journal of Gastroenterology,2005,11(21):3234-3239. 被引量:15
  • 4段红梅,申昆玲.慢性活动性EB病毒感染的诊断标准和治疗[J].实用儿科临床杂志,2006,21(10):638-640. 被引量:25
  • 5Kimura H,Morishima T,Kanegane H,et al.Prognostic factors for chronic active Epstein-Barr virus infection.J Infect Dis,2003,187(4):527-533.
  • 6Kimura H,Hoshino Y,Kanegane H,et al.Clinical and virologic characteristics of chronic active Epstein-Barr virus infection.Blood,2001,98 (2):280-286.
  • 7Cohen JI,Kimura H,Nakamura S,et al.Epstein-Barr virusassociated lymphoproliferative disease in non-immunocompromised hosts:a status report and summary of an international meeting,8-9September 2008.Ann Oncol,2009,20(9):1472-1482.
  • 8Swerdlow SH,Campo E,Harris NL,et al.World Health Organization classification of tumors.WHO classification of tumors of haematopoietic and lymphoid tissues.Lyon:IARC Press,2008.
  • 9Park S,Kim K,Kim WS,et al.Systemic EBV+ T-cell lymphoma in elderly patients:comparison with children and young adult patients.Virchows Arch,2008,453 (2):155-163.
  • 10Ohshima K,Kimura H,Yoshino T,et al.Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults:overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.Pathol Int,2008,58(4):209-217.

共引文献110

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部